Although the use of prostate-specific antigen (PSA) for screening of asymptomatic men for PC has reduced disease-specific mortality, screening is associated with overdiagnosis and additional markers are required for PC diagnosis and prognosis [3]. Here, KLK3 is linked to pachyonychia congenita.